Quiz Ref ID Achalasia is an esophageal motility disorder characterized by absent peristalsis in the esophageal body and impaired relaxation of the lower esophageal sphincter (LES), which hampers esophageal emptying, that typically results in symptoms of dysphagia, regurgitation of food, chest pain, and weight loss.
1 Treatment for patients with achalasia involves medical, endoscopic, and surgical options. Endoscopic pneumatic dilation is the most commonly performed treatment worldwide for patients with achalasia. The procedure is minimally invasive and the long-term therapeutic rate of success, defined as a reduction of the Eckardt score to less than or equal to 3 and the absence of the need for re-treatment, is 50% to 85%.
2-5 Approximately 1% to 3% of endoscopic pneumatic dilation procedures are complicated by a perforation.
2,6,7 Laparoscopic Heller myotomy combined with an antireflux procedure offers a more permanent solution for patients with achalasia, with success rates of 80% to 90%.
2,3,6 However, this technique is considerably more invasive and can be associated with severe complications, including transmural perforation (4%-10%), bleeding, or infection, and, therefore, is generally considered as treatment for patients who do not respond to pneumatic dilation.
6